Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jim Wright, MD
Hamilton Regional Cancer Centre
Study Chair - Mark Levine, MD
Ontarion Clinical Oncology Group
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tom Baker Cancer Centre
Calgary, Alberta, Canada
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Cancer Care Manitoba
Winnipeg, Manitoba, Canada
- St. John Regional Hospital
Saint John, New Brunswick, Canada
- Newfoundland Cancer Treatment & Research Foundation
St. John's, Newfoundland and Labrador, Canada
- Nova Scotia Cancer Centre
Halifax, Nova Scotia, Canada
- Northeastern Ontario Regional Cancer Centre
Greater Sudbury, Ontario, Canada
- Hamilton Regional Cancer Centre (juravinski)
Hamilton, Ontario, Canada
- London Regional Cancer Centre
London, Ontario, Canada
- Hotel Dieu Hospital
Saint Catherines, Ontario, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Toronto East General Hospital
Toronto, Ontario, Canada
- Toronto Sunnybrook Regional Cancer Centre
Toronto, Ontario, Canada
- Windsor Regional Cancer Centre
Windsor, Ontario, Canada
- Mcgill University Clinical Trials Operations
Montreal, Quebec, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2001
- Primary completion
- —
- Completion
- 30 Apr 2004
- Last update posted
- 2 Apr 2024
- Registered enrollment
- 70
- Registry id
- NCT00310232
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.